The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Aug. 07, 2018
Applicant:

Intervene Immune, Inc., Manhattan Beach, CA (US);

Inventors:

Gregory M. Fahy, Norco, CA (US);

Robert T. Brooke, Manhattan Beach, CA (US);

Assignee:

INTERVENE IMMUNE INC., Manhattan Beach, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/27 (2006.01); A61K 45/06 (2006.01); C07K 14/61 (2006.01); A61K 31/5685 (2006.01);
U.S. Cl.
CPC ...
A61K 38/27 (2013.01); A61K 31/5685 (2013.01);
Abstract

A combination of medications and medication doses is disclosed whereby age-related changes in systemic inflammation, cancer risk, heart disease risk, CD38 expression, hair color, thymotrophic hormones, immune cell populations, the CD4/CD8 cell ratio, bone marrow density, thymus structure, kidney function, and epigenetic age can be reversed in humans. Surprisingly, agents that accelerate the growth of cells reduce cancer risk, agents that intensify immune responses attenuate age-related inflammation, agents with no prior connection to hair color reverse age-related hair whitening, and a combination of agents that induces IGF-1, a hormone previously thought to drive systemic aging, results in a reversal of systemic aging as documented by an epigenetic clock. Medication combinations useful in the present invention include human growth hormone (GH) or GH releasers, dehydroepiandrosterone (DHEA), and metformin.


Find Patent Forward Citations

Loading…